Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Conducting Internal Quality Audits for Cream Manufacturing – V 2.0

Posted on By

Creams: SOP for Conducting Internal Quality Audits for Cream Manufacturing – V 2.0

Standard Operating Procedure for Conducting Internal Quality Audits for Cream Manufacturing

Department Creams
SOP No. SOP/CRM/185/2025
Supersedes SOP/CRM/185/2022
Page No. Page 1 of 6
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the process for conducting internal quality audits in the cream manufacturing department. This ensures compliance with GMP, regulatory requirements, and internal quality standards, helping to identify areas for improvement and ensuring the continued production of high-quality cream products.

2. Scope

This SOP applies to all internal quality audits conducted in the cream manufacturing department. It includes audits of production processes, equipment, documentation, and quality control activities, to ensure compliance with established standards and to identify opportunities for improvement.

3. Responsibilities

  • Quality Assurance (QA) Team: Responsible for planning and coordinating internal audits, reviewing audit findings, and ensuring corrective and preventive actions (CAPA) are implemented. The QA team also maintains audit records and reports.
  • Production Team: Responsible for providing necessary documents, access to production areas, and supporting the audit process. They must address any issues identified during the audit and implement corrective actions as required.
  • Department Heads: Responsible for overseeing
the implementation of corrective actions and ensuring compliance with audit findings within their respective departments.
  • Regulatory Affairs: Responsible for ensuring that audit processes comply with external regulatory requirements and that any changes resulting from audits are communicated to regulatory bodies if necessary.
  • 4. Accountability

    The QA Manager is accountable for planning, conducting, and managing internal audits. The Production Manager is responsible for ensuring the implementation of corrective actions resulting from audit findings. Department Heads must ensure compliance with audit findings within their departments.

    5. Procedure

    5.1 Planning the Internal Audit

    1. The QA Manager is responsible for planning the internal audit schedule. Audits should be conducted at least once every quarter or as required by regulatory guidelines.
    2. The QA team will develop an audit checklist based on the relevant SOPs, production records, quality control logs, and regulatory requirements. The checklist will cover areas such as:
      • Production processes
      • Equipment maintenance and calibration
      • Raw material handling and storage
      • Employee training and qualifications
      • Documentation and record-keeping
      • Compliance with GMP guidelines
    3. The audit schedule and checklist will be communicated to the relevant departments in advance to ensure they are prepared for the audit.

    5.2 Conducting the Audit

    1. The QA team will conduct the audit by reviewing documentation, inspecting production areas, and interviewing personnel involved in the manufacturing process.
    2. During the audit, the team will:
      • Verify that production processes follow approved SOPs and specifications.
      • Ensure that all records are complete, accurate, and compliant with internal and regulatory standards.
      • Inspect equipment for cleanliness, calibration, and proper functioning.
      • Assess employee training records to ensure staff is qualified to perform their tasks.
      • Identify any discrepancies, non-compliance issues, or areas for improvement.
    3. Findings will be documented in the Internal Audit Report (Annexure-1) with a description of the issue, its impact, and the recommended corrective actions.

    5.3 Reporting the Findings

    1. After the audit, the QA team will compile the audit findings into a report. The report should include:
      • Summary of audit findings
      • Non-compliance issues and deviations from GMP or internal procedures
      • Recommended corrective actions and preventive actions
      • Deadline for addressing the issues
    2. The Internal Audit Report will be shared with the Production Manager, Department Heads, and relevant stakeholders for review and action.
    3. If major deviations or non-compliance issues are identified, the QA team may request an immediate meeting with the management team to discuss the findings and plan corrective actions.

    5.4 Implementing Corrective and Preventive Actions (CAPA)

    1. Following the audit, the responsible departments must implement corrective actions to address any identified non-compliance issues or deviations.
    2. The CAPA process should include:
      • Identifying the root cause of the issue
      • Implementing corrective actions to fix the immediate issue
      • Implementing preventive actions to prevent recurrence of the issue
      • Assigning responsibility for implementing and monitoring the actions
    3. The QA team will review the proposed corrective and preventive actions to ensure they are adequate and effective.
    4. Once the corrective actions are implemented, the QA team will verify their effectiveness through follow-up audits or inspections.

    5.5 Monitoring and Follow-up

    1. The QA team will monitor the implementation of corrective actions and ensure that they are completed within the agreed timeline.
    2. Follow-up audits will be conducted to assess the effectiveness of corrective actions. If necessary, further actions will be taken to ensure that the issue has been fully resolved.
    3. All audit-related documentation, including the Internal Audit Report, CAPA log, and follow-up audit reports, will be maintained for future reference and regulatory inspections.

    5.6 Documentation and Record-Keeping

    1. All audit reports, CAPA logs, and related documentation will be stored and maintained in compliance with GMP guidelines for record-keeping.
    2. Documents should be retained for at least two years or as required by regulatory guidelines.
    3. Audit records must be organized and readily available for review during internal or external audits.

    6. Abbreviations

    • GMP: Good Manufacturing Practices
    • QA: Quality Assurance
    • QC: Quality Control
    • PPE: Personal Protective Equipment
    • SOP: Standard Operating Procedure
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Annexure-1: Internal Audit Report
    2. Annexure-2: CAPA Log

    8. References

    • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
    • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • FDA Guidance for Industry: Internal Quality Audits

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Internal Audit Report

    Audit Area Findings Corrective Action Responsible Person Timeline
    Production Process Deviation in temperature control Calibrate temperature controllers Production Manager 27/01/2026

    Annexure-2: CAPA Log

    Corrective Action Description Preventive Action Description Implementation Date Responsible Person
    Recalibrate temperature control system Schedule monthly calibration 27/01/2026 Maintenance Supervisor

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/03/2024 1.0 Initial Version New SOP Creation QA Head
    01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
    See also  Creams: SOP for Verifying Cleaning Validation Reports - V 2.0
    Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

    Post navigation

    Previous Post: BA-BE Studies: SOP for Analyst Proficiency Testing – V 2.0
    Next Post: Biosimilars: SOP for Inactivation of Used Culture Broth – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version